Treatment of vulvovaginal candidiasis: a review of the literature

Acta Dermatovenerologica Alpina, Pannonica, Et Adriatica
Andraž DovnikIztok Takač

Abstract

Vulvovaginal candidiasis (VVC) affects around three-quarters of all women during their reproductive age, although the exact incidence of VVC is difficult to determine because many patients are self-treated. The infections are divided into complicated and uncomplicated. Uncomplicated VVC is most effectively treated with local azoles. Oral treatment with a single dose of fluconazole is also effective for treating uncomplicated VVC. Treatment of complicated VVC is prolonged and most commonly consists of multiple doses of oral fluconazole or at least 1 week of local azoles. The role of probiotics in treating VVC is still disputed. This article presents a review of the literature on the various treatment options for VVC. Treatment for the most common pathogens that cause complicated VVC is also discussed.

Associated Clinical Trials

Apr 14, 2017

Citations

Apr 5, 2019·Lasers in Medical Science·Mariana RobattoPatrícia Lordelo
Jan 31, 2020·Frontiers in Microbiology·Fernanda Walt Mendes da Silva de BastianiKelly Ishida
Jan 21, 2021·Drug Delivery and Translational Research·Ana Carolina S RéTaís Gratieri

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.